Plante Moran Financial Advisors, LLC Galectin Therapeutics Inc Transaction History

Plante Moran Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.07 - $3.8 $3,721 - $6,832	-1,798 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$2.07 - $5.1 $206 - $509	100 Added 5.89%	1,798 $6,000
Q4 2020 Feb 09, 2021	BUY	$2.24 - $2.87 $672 - $861	300 Added 21.46%	1,698 $4,000
Q1 2020 May 07, 2020	BUY	$1.51 - $3.0 $300 - $597	199 Added 16.6%	1,398 $3,000
Q3 2019 Nov 13, 2019	SELL	$3.0 - $4.05 $1,800 - $2,430	-600 Reduced 33.35%	1,199 $4,000
Q2 2019 Aug 13, 2019	BUY	$3.61 - $5.0 $6,494 - $8,995	1,799 New	1,799 $7,000

9.73M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $72.5M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.